News
Mar 22, 2016
CardioCell Expands Chronic Heart Failure Phase Ila Clinical Trial To MedStar Washington Hospital Center
CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, welcomes MedStar Washington Hospital Center as the newest site for its Phase IIa chronic heart failure (HF) clinical trial. READ FULL ARTICLE